{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T22:22:20Z","timestamp":1776378140695,"version":"3.51.2"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T00:00:00Z","timestamp":1586304000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T00:00:00Z","timestamp":1586304000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1038\/s41433-020-0865-5","type":"journal-article","created":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T18:03:56Z","timestamp":1586369036000},"page":"1494-1496","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Meibomian gland dysfunction, dropout and distress: emerging therapies"],"prefix":"10.1038","volume":"34","author":[{"given":"Ali","family":"Hassan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7683-2741","authenticated-orcid":false,"given":"Shafi","family":"Balal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sajjad","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,8]]},"reference":[{"issue":"Apr","key":"865_CR1","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1097\/ICO.0000000000002235","volume":"39","author":"A Tauber","year":"2020","unstructured":"Tauber J. A 6-week, prospective, randomized, single-masked study of lifitegrast ophthalmic solution 5% versus thermal pulsation procedure for treatment of inflammatory meibomian gland dysfunction. Cornea. 2020;39(Apr):403\u20137.","journal-title":"Cornea"},{"key":"865_CR2","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1167\/iovs.10-6997e","volume":"52","author":"DA Schaumberg","year":"2011","unstructured":"Schaumberg DA, Nichols JJ, Papas EB, Tong L, Uchino M, Nichols KK. The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for, MGD. Investig Ophthalmol Vis Sci. 2011;52:1994\u20132005.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"865_CR3","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/S0161-6420(98)98033-2","volume":"105","author":"J Shimazaki","year":"1998","unstructured":"Shimazaki J, Goto E, Ono M, Shimmura S, Tsubota K. Meibomian gland dysfunction in patients with Sj\u00f6gren syndrome. Ophthalmology. 1998;105:1485\u20138.","journal-title":"Ophthalmology"},{"key":"865_CR4","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1136\/bjophthalmol-2015-307415","volume":"100","author":"C Baudouin","year":"2016","unstructured":"Baudouin C, Messmer EM, Aragona P, Geerling G, Akova YA, Ben\u00edtez-del-Castillo J, et al. Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction. Br J Ophthalmol. 2016;100:300\u20136.","journal-title":"Br J Ophthalmol"},{"key":"865_CR5","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.jtos.2017.05.011","volume":"15","author":"AJ Bron","year":"2017","unstructured":"Bron AJ, de Paiva CS, Chauhan SK, Bonini S, Gabison EE, Jain S, et al. Tfos dews ii pathophysiology report. Ocul Surf. 2017;15:438\u2013510.","journal-title":"Ocul Surf"},{"key":"865_CR6","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1167\/iovs.10-6997a","volume":"52","author":"KK Nichols","year":"2011","unstructured":"Nichols KK, Foulks GN, Bron AJ, Glasgow BJ, Dogru M, Tsubota K, et al. The international workshop on meibomian gland dysfunction: executive summary. Investig Ophthalmol Vis Sci. 2011;52:1922\u20139.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"865_CR7","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1097\/ICL.0000000000000228","volume":"42","author":"Y Zhao","year":"2016","unstructured":"Zhao Y, Veerappan A, Yeo S, Rooney DM, Acharya RU, Tan JH. et al. Clinical trial of thermal pulsation (LipiFlow) in meibomian gland dysfunction with preteatment meibography. Eye Contact Lens. 2016;42:339","journal-title":"Eye Contact Lens"},{"key":"865_CR8","doi-asserted-by":"publisher","first-page":"161","DOI":"10.2147\/OPTH.S150433","volume":"12","author":"KB Hagen","year":"2018","unstructured":"Hagen KB, Bedi R, Blackie CA, Christenson-Akagi KJ. Comparison of a single-dose vectored thermal pulsation procedure with a 3-month course of daily oral doxycycline for moderate-to-severe meibomian gland dysfunction. Clin Ophthalmol (Auckl, NZ). 2018;12:161.","journal-title":"Clin Ophthalmol (Auckl, NZ)"},{"key":"865_CR9","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/lsm.10145","volume":"32","author":"C Raulin","year":"2003","unstructured":"Raulin C, Greve B, Grema H. IPL technology: a review. Lasers Surg Med. 2003;32:78\u201387.","journal-title":"Lasers Surg Med"},{"key":"865_CR10","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1167\/iovs.14-15764","volume":"56","author":"JP Craig","year":"2015","unstructured":"Craig JP, Chen YH, Turnbull PR. Prospective trial of intense pulsed light for the treatment of meibomian gland dysfunction. Invest Ophthalmol Vis Sci. 2015;56:1965\u201370.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"865_CR11","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jtos.2018.11.004","volume":"17","author":"R Arita","year":"2019","unstructured":"Arita R, Fukuoka S, Morishige N. Therapeutic efficacy of intense pulsed light in patients with refractory meibomian gland dysfunction. Ocul Surf. 2019;17:104\u201310.","journal-title":"Ocul Surf"},{"key":"865_CR12","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1089\/pho.2017.4402","volume":"36","author":"B Rong","year":"2018","unstructured":"Rong B, Tang Y, Tu P, et al. Intense pulsed light applied directly on eyelids combined with meibomian gland expression to treat meibomian gland dysfunction. Photomed Laser Surg. 2018;36:326\u201332.","journal-title":"Photomed Laser Surg"},{"key":"865_CR13","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1089\/pho.2018.4499","volume":"36","author":"B Rong","year":"2018","unstructured":"Rong B, Tang Y, Liu R, Tu P, Qiao J, Song W, et al. Long\u2010term effects of intense pulsed light combined with meibomian gland expression in the treatment of meibomian gland dysfunction. Photomed Laser Surg. 2018;36:562\u20137.","journal-title":"Photomed Laser Surg"},{"key":"865_CR14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ajo.2017.08.021","volume":"183","author":"R Liu","year":"2017","unstructured":"Liu R, Rong B, Tu P, Tang Y, Song W, Toyos R, et al. Analysis of cytokine levels in tears and clinical correlations after intense pulsed light treating meibomian gland dysfunction. Am J Ophthalmol. 2017;183:81\u201390.","journal-title":"Am J Ophthalmol"},{"key":"865_CR15","first-page":"1","volume":"11","author":"T Ho","year":"2020","unstructured":"Ho T, Teo L. Retinal toxicity from intense pulsed light therapy: a case report. EC Ophthalmol. 2020;11:1\u20134.","journal-title":"EC Ophthalmol"},{"key":"865_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tox.2014.02.014","volume":"320","author":"Y Liu","year":"2014","unstructured":"Liu Y, Kam WR, Ding J, Sullivan DA. One man\u2019s poison is another man\u2019s meat. Using azithromycin-induced phospholipidosis to promote ocular surface health. Toxicology. 2014;320:1\u20135.","journal-title":"Toxicology"},{"key":"865_CR17","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1097\/ICO.0b013e318207fc42","volume":"30","author":"TZ Igami","year":"2011","unstructured":"Igami TZ, Holzchuh R, Osaki TH, Santo RM, Kara-Jose N, Hida RY. Oral azithromycin for treatment of posterior blepharitis. Cornea. 2011;30(Oct):1145\u20139.","journal-title":"Cornea"},{"key":"865_CR18","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1097\/ICO.0b013e3181cda38f","volume":"29","author":"GN Foulks","year":"2010","unstructured":"Foulks GN, Borchman D, Yappert M, Sung-Hye K, McKay JW. Topical azithromycin therapy of meibomian gland dysfunction: clinical response and lipid alterations. Cornea 2010;29:781.","journal-title":"Cornea"},{"issue":"Mar","key":"865_CR19","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/ICO.0000000000002233","volume":"39","author":"E Ciloglu","year":"2020","unstructured":"Ciloglu E, \u00d6zcan AA, Incekalan T, Unal F. The role of topical azithromycin in the treatment of meibomian gland dysfunction. Cornea. 2020;39(Mar):321\u20134.","journal-title":"Cornea"},{"key":"865_CR20","first-page":"336","volume":"106","author":"MS Macsai","year":"2008","unstructured":"Macsai MS. The role of omega-3 dietary supplementation in blepharitis and meibomian gland dysfunction (an AOS thesis). Trans Am Ophthalmological Soc. 2008;106:336.","journal-title":"Trans Am Ophthalmological Soc"},{"key":"865_CR21","doi-asserted-by":"publisher","first-page":"e677","DOI":"10.1111\/aos.13428","volume":"95","author":"I Molina-Leyva","year":"2017","unstructured":"Molina-Leyva I, Molina-Leyva A, Bueno-Cavanillas A. Efficacy of nutritional supplementation with omega-3 and omega-6 fatty acids in dry eye syndrome: a systematic review of randomized clinical trials. Acta Ophthalmol. 2017;95:e677\u201385.","journal-title":"Acta Ophthalmol"},{"key":"865_CR22","doi-asserted-by":"crossref","unstructured":"Oydanich M, Maguire MG, Pistilli M, Hamrah P, Greiner JV, Lin MC, et al. Management study research group. effects of omega-3 supplementation on exploratory outcomes in the dry eye assessment and management study. Ophthalmology. 2020;127:136\u20138.","DOI":"10.1016\/j.ophtha.2019.07.009"},{"key":"865_CR23","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.2147\/OPTH.S113437","volume":"11","author":"MK Rhee","year":"2017","unstructured":"Rhee MK, Mah FS. Clinical utility of cyclosporine (CsA) ophthalmic emulsion 0.05% for symptomatic relief in people with chronic dry eye: a review of the literature. Clin Ophthalmol (Auckl, NZ). 2017;11:1157.","journal-title":"Clin Ophthalmol (Auckl, NZ)"},{"key":"865_CR24","first-page":"593","volume":"11","author":"HY Kim","year":"2018","unstructured":"Kim HY, Lee JE, Oh HN, Song JW, Han SY, Lee JS. Clinical efficacy of combined topical 0.05% cyclosporine a and 0.1% sodium hyaluronate in the dry eyes with meibomian gland dysfunction. Int J Ophthalmol. 2018;11:593.","journal-title":"Int J Ophthalmol"},{"key":"865_CR25","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.2147\/OPTH.S110557","volume":"10","author":"CP Semba","year":"2016","unstructured":"Semba CP, Gadek TR. Development of lifitegrast: a novel T-cell inhibitor for the treatment of dry eye disease. Clin Ophthalmol (Auckl, NZ). 2016;10:1083.","journal-title":"Clin Ophthalmol (Auckl, NZ)"},{"issue":"Oct","key":"865_CR26","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1097\/ACI.0b013e32833df9f4","volume":"10","author":"J Liu","year":"2010","unstructured":"Liu J, Sheha H, Tseng SC. Pathogenic role of demodex mites in blepharitis. Curr Opin Allergy Clin Immunol. 2010;10(Oct):505.","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"865_CR27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2147\/OPTO.S142708","volume":"10","author":"SR Fromstein","year":"2018","unstructured":"Fromstein SR, Harthan JS, Patel J, Opitz DL. Demodex blepharitis: clinical perspectives. Clin Optom. 2018;10:57.","journal-title":"Clin Optom"},{"key":"865_CR28","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1136\/bjophthalmol-2012-302668","volume":"97","author":"R Arita","year":"2013","unstructured":"Arita R, Suehiro J, Haraguchi T, Maeda S, Maeda K, Tokoro H, et al. Topical diquafosol for patients with obstructive meibomian gland dysfunction. Br J Ophthalmol. 2013;97:725\u20139.","journal-title":"Br J Ophthalmol"},{"key":"865_CR29","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/cxo.12524","volume":"100","author":"JM Albietz","year":"2017","unstructured":"Albietz JM, Schmid KL. Randomised controlled trial of topical antibacterial Manuka (Leptospermum species) honey for evaporative dry eye due to meibomian gland dysfunction. Clin Exp Optom. 2017;100:603\u201315.","journal-title":"Clin Exp Optom"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41433-020-0865-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41433-020-0865-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41433-020-0865-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:11:04Z","timestamp":1684617064000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-020-0865-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,8]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["865"],"URL":"https:\/\/doi.org\/10.1038\/s41433-020-0865-5","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,8]]},"assertion":[{"value":"22 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}